Yuan-yuan Zhang, Jia-Wei Xu, Yang Liu, Wei Qiu, Pei-Ning Bai, Yi Zeng, & Qing Wang. (2023). Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYuan-yuan Zhang, Jia-Wei Xu, Yang Liu, Wei Qiu, Pei-Ning Bai, Yi Zeng, and Qing Wang. Post-marketing Safety Surveillance Study of a 9-valent Human Papillomavirus Vaccine in Individuals Aged 16-26 Years in Chongqing, China. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationYuan-yuan Zhang, et al. Post-marketing Safety Surveillance Study of a 9-valent Human Papillomavirus Vaccine in Individuals Aged 16-26 Years in Chongqing, China. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.